David T. Howton, SVP, General Counsel at Sarepta Therapeutics, Inc. (SRPT), sold 30,000 shares at $140.00 ($4.2M) on 2019-02-01, disclosed to the SEC on 2019-02-01.
Open-market sale of $4.2M SRPT by SVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SLDB | SELL | 2026-02-02 | $486K | — | Filing → |
| SLDB | SELL | 2025-12-04 | $25K | — | Filing → |
| SLDB | SELL | 2025-02-18 | $22K | — | Filing → |